Go offline with the Player FM app!
Spotlight on human rights: who owns COVID-19 vaccines and why should investors care?
Archived series ("Inactive feed" status)
When? This feed was archived on August 02, 2023 22:50 (). Last successful fetch was on April 03, 2023 12:21 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 302708068 series 1230045
In the fourth episode of the PRI’s human rights podcast series, Nikolaj Pedersen speaks to biomedical researcher, health rights advocate, and Head of Policy at the UCL Institute for Innovation and Public Purpose, Els Torreele and Peter Hughes, fund manager at AXA Investment Managers about COVID-19 vaccine ownership and distribution and what investors can do to promote fair and equal access.
As of July this year, more than 80% of vaccine doses globally had been given to individuals in high and upper-middle-income countries. Only 1% of people in low-income countries at the time had had at least one dose.
The United Nations commissioner on human rights has stated that "affordable, non-discriminatory access to the vaccine is a human right" and because of the failure to provide fair and equal access to the vaccine the World Health Organisation has stated that the world "is on the brink of a catastrophic moral failure".
The economic consequences are also grave with an estimated $9.2 trillion lost if governments fail to ensure that developing economies have access to COVID-19 vaccines
What is wrong with the current research and development system? Why does ownership of IP, know-how and technology matter? And what can investors do?
Listen to this episode as we explore these questions with our esteemed guests.
Find a trascript of this episode here: https://bit.ly/3CqbNhN
Interested in the resources discussed in this episode?
Investors issue urgent call for “fair and equitable” global response to COVID-19: https://accesstomedicinefoundation.org/news/investors-issue-urgent-call-for-fair-and-equitable-global-response-to-covid-19
Study shows vaccine nationalism could cost rich countries US$4.5 trillion: https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/
Campaigners warn that 9 out of 10 people in poor countries are set to miss out on COVID-19 vaccine next year: https://www.oxfam.org/en/press-releases/campaigners-warn-9-out-10-people-poor-countries-are-set-miss-out-covid-19-vaccine
101 episodes
Archived series ("Inactive feed" status)
When? This feed was archived on August 02, 2023 22:50 (). Last successful fetch was on April 03, 2023 12:21 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 302708068 series 1230045
In the fourth episode of the PRI’s human rights podcast series, Nikolaj Pedersen speaks to biomedical researcher, health rights advocate, and Head of Policy at the UCL Institute for Innovation and Public Purpose, Els Torreele and Peter Hughes, fund manager at AXA Investment Managers about COVID-19 vaccine ownership and distribution and what investors can do to promote fair and equal access.
As of July this year, more than 80% of vaccine doses globally had been given to individuals in high and upper-middle-income countries. Only 1% of people in low-income countries at the time had had at least one dose.
The United Nations commissioner on human rights has stated that "affordable, non-discriminatory access to the vaccine is a human right" and because of the failure to provide fair and equal access to the vaccine the World Health Organisation has stated that the world "is on the brink of a catastrophic moral failure".
The economic consequences are also grave with an estimated $9.2 trillion lost if governments fail to ensure that developing economies have access to COVID-19 vaccines
What is wrong with the current research and development system? Why does ownership of IP, know-how and technology matter? And what can investors do?
Listen to this episode as we explore these questions with our esteemed guests.
Find a trascript of this episode here: https://bit.ly/3CqbNhN
Interested in the resources discussed in this episode?
Investors issue urgent call for “fair and equitable” global response to COVID-19: https://accesstomedicinefoundation.org/news/investors-issue-urgent-call-for-fair-and-equitable-global-response-to-covid-19
Study shows vaccine nationalism could cost rich countries US$4.5 trillion: https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/
Campaigners warn that 9 out of 10 people in poor countries are set to miss out on COVID-19 vaccine next year: https://www.oxfam.org/en/press-releases/campaigners-warn-9-out-10-people-poor-countries-are-set-miss-out-covid-19-vaccine
101 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.